<DOC>
	<DOCNO>NCT02050425</DOCNO>
	<brief_summary>Clinical trial patient obstructive sleep apnoea randomise either continue withdraw continuous positive airway pressure therapy identify disease-specific exhaled breath pattern mass spectrometry .</brief_summary>
	<brief_title>Breath Analysis Obstructive Sleep Apnoea</brief_title>
	<detailed_description>Randomised placebo-controlled trial ( therapeutic vs. subtherapeutic continuous positive airway pressure [ CPAP ] ) include 30 OSA patient define effect CPAP withdrawal ( subtherapeutic CPAP ) composition exhale breath analysed mass spectrometry identification OSA specific marker .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>Confirmed OSA ( time original diagnosis ) oxygen desaturation index ( ODI ) &gt; 20/h . Currently &gt; 20/h oxygen desaturations ( â‰¥4 % dip ) ambulatory nocturnal pulse oximetry perform last night 4night period without CPAP . Treated CPAP 12 month , minimum compliance 4h/night , apnoeahypopnoea index ( AHI ) &lt; 10 treatment ( accord CPAP download ) current ESS &lt; 10 . Age 20 75 year trial entry . Previous ventilatory failure ( awake SpO2 &lt; 93 % PaCO2 &gt; 6kPa ) . Unstable , untreated coronary peripheral artery disease , severe arterial hypertension hypotension ( &gt; 180/110 &lt; 90/60mmHg ) Previously diagnose CheyneStokes breathe . Current professional driver ; previous sleep related accident . Acute inflammatory disease . Acute chronic hepatic disease . Renal failure renal replacement therapy . Use inhale drug .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>OSA</keyword>
	<keyword>CPAP</keyword>
	<keyword>exhale breath</keyword>
</DOC>